We’re very happy to announce that we’ve been placed in Pharma Tech Outlook’s “Top Pharmacovigilance Solution Providers 2021” list. This annual list is compiled by Pharma Tech Outlook of the 10 companies that it believes are at the forefront of providing pharmacovigilance solutions and transforming businesses.
As part of this placement, the publication spoke to Dialog Solutions’ General Manager Michael Rai about the growth of Dialog Solutions over the past year, what makes us stand out against the competition, and our plans for 2021. Here’s an excerpt:
Michael Rai, general manager of Dialog Solutions, says, “We provide our clients with the right tools needed to review literature articles in the quickest time possible. At every stage of the biomedical literature monitoring process, we help pharmaceutical companies save time and money.”
But what’s truly unique about the Drug Safety Triager solution is it seamlessly ingests relevant alert results and then deduplicates and ranks ICSRs for relevancy. This helps reviewers to improve the quality, speed, and efficiency of the literature review process. The Drug Safety Triager is also fully validated and compliant with the reporting requirements of the regulators, including the FDA, EMA, and PMDA. “There are a lot of vendors out in the marketplace today that offer different aspects of biomedical literature monitoring as outsourced services. We do all of it under one roof, providing us a strong understanding of the areas of the process to continually improve,” informs Rai.
Take a look at the full article to understand why Dialog Solutions was chosen as one of the top 10 pharmacovigilance solution providers, and how we’re helping some of the world’s biggest pharmaceutical companies. Click on the image below to read the whole article:
